OrganaBio, founded in 2018, is a provider of cell therapy starting materials and clinical cell processing and cryopreservation services.
Headquartered in Miami, FL., OrganaBio works with GaiaGift and HemaCenter, wholly owned birth tissue donation and apheresis centers respectively, to collect birth tissue and peripheral blood from which the company supplies highly characterized fresh, frozen or cryopreserved cord blood units, leukopaks, and isolated cells at both research grade and GMP, to support therapeutics developers throughout the development journey. OrganaBio also leverages its extensive expertise in cell isolation and cryopreservation to provide localized and rapid PBMC isolation from whole blood, analytical testing, cryopreservation and cold storage of clinical trial samples, as well as autologous apheresis and cryopreservation to support cell therapy delivery from both its East and West Coast facilities in Miami, FL and Irvine, CA.